• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

皮肤科医生眼中的川崎病。

Kawasaki disease for dermatologists.

作者信息

Gupta Aman, Singh Surjit

机构信息

Allergy Immunology Unit, Department of Pediatrics, PGIMER, Chandigarh, India.

出版信息

Indian Dermatol Online J. 2016 Nov-Dec;7(6):461-470. doi: 10.4103/2229-5178.193903.

DOI:10.4103/2229-5178.193903
PMID:27990380
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5134159/
Abstract

Kawasaki disease (KD) is a systemic vasculitis that mostly affects children below the age of 5. The vasculitis involves arteries of medium size, especially the coronaries. Various etiologies have been proposed including association with micro-organisms, bacterial superantigens, and genetic factors, however, the exact cause remains unknown. There is no specific laboratory test for KD. Diagnosis is clinical and depends upon the presence of fever for ≥5 days and 4 or more of five principal features, viz. polymorphous exanthem, extremity changes, mucosal changes involving the lips and oral cavity, bilateral bulbar conjunctival injection, and unilateral cervical lymphadenopathy. The term "incomplete KD" refers to the presence of fever and less than four principal clinical features. Recognition of this group of patients is important because it is usually seen in infants and risk of coronary abnormalities is increased probably because of delays in diagnosis. However, what appears to be "incomplete" at a given point of time may not actually be so because some of the features may have already subsided and others may evolve over time. Hence, a detailed dermatological examination is warranted in all cases, especially in incomplete KD, to ensure timely diagnosis. Although KD is a self-limiting disease in most patients, coronary artery abnormalities (CAAs) including coronary dilatations and aneurysms may develop in up to 25% of untreated patients. CAAs are the most common cause of morbidity and mortality in patients with KD. Treatment is aimed at reducing inflammation and consists of intravenous immunoglobulin (IVIG) along with aspirin. Despite treatment, some patients may still develop CAAs, and hence, long-term follow up is of utmost importance.

摘要

川崎病(KD)是一种主要影响5岁以下儿童的全身性血管炎。这种血管炎累及中等大小的动脉,尤其是冠状动脉。已经提出了各种病因,包括与微生物、细菌超抗原和遗传因素的关联,然而,确切病因仍然未知。目前尚无针对川崎病的特异性实验室检查。诊断依靠临床症状,取决于发热≥5天以及具备五项主要特征中的4项或更多,即多形性皮疹、四肢变化、涉及嘴唇和口腔的黏膜变化、双侧球结膜充血以及单侧颈部淋巴结肿大。“不完全川崎病”一词指的是存在发热但主要临床特征少于4项。识别这组患者很重要,因为这类情况通常见于婴儿,可能由于诊断延迟导致冠状动脉异常的风险增加。然而,在某个特定时间点看似“不完全”的情况实际上可能并非如此,因为一些特征可能已经消退,而其他特征可能会随时间演变。因此,所有病例,尤其是不完全川崎病,都需要进行详细的皮肤科检查,以确保及时诊断。尽管川崎病在大多数患者中是一种自限性疾病,但在未经治疗的患者中,高达25%可能会出现包括冠状动脉扩张和动脉瘤在内的冠状动脉异常(CAA)。冠状动脉异常是川崎病患者发病和死亡的最常见原因。治疗旨在减轻炎症,包括静脉注射免疫球蛋白(IVIG)和阿司匹林。尽管进行了治疗,一些患者仍可能出现冠状动脉异常,因此,长期随访至关重要。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/29b2/5134159/cd061d4f1cd5/IDOJ-7-461-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/29b2/5134159/7a1b843e5358/IDOJ-7-461-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/29b2/5134159/066b62f051d9/IDOJ-7-461-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/29b2/5134159/b860cbe5df80/IDOJ-7-461-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/29b2/5134159/d64780160a1e/IDOJ-7-461-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/29b2/5134159/e16bc0d4f17d/IDOJ-7-461-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/29b2/5134159/be808a549ca8/IDOJ-7-461-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/29b2/5134159/a7c81c615882/IDOJ-7-461-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/29b2/5134159/cd061d4f1cd5/IDOJ-7-461-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/29b2/5134159/7a1b843e5358/IDOJ-7-461-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/29b2/5134159/066b62f051d9/IDOJ-7-461-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/29b2/5134159/b860cbe5df80/IDOJ-7-461-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/29b2/5134159/d64780160a1e/IDOJ-7-461-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/29b2/5134159/e16bc0d4f17d/IDOJ-7-461-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/29b2/5134159/be808a549ca8/IDOJ-7-461-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/29b2/5134159/a7c81c615882/IDOJ-7-461-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/29b2/5134159/cd061d4f1cd5/IDOJ-7-461-g009.jpg

相似文献

1
Kawasaki disease for dermatologists.皮肤科医生眼中的川崎病。
Indian Dermatol Online J. 2016 Nov-Dec;7(6):461-470. doi: 10.4103/2229-5178.193903.
2
Intravenous immunoglobulin for the treatment of Kawasaki disease.静脉注射免疫球蛋白治疗川崎病。
Cochrane Database Syst Rev. 2023 Jan 25;1(1):CD014884. doi: 10.1002/14651858.CD014884.pub2.
3
Kawasaki disease complicating bilateral facial nerve palsy and giant coronary artery aneurysms: A case report.川崎病并发双侧面神经麻痹和巨大冠状动脉瘤:一例报告。
Medicine (Baltimore). 2019 Feb;98(7):e14395. doi: 10.1097/MD.0000000000014395.
4
Giant bilateral axillary artery aneurysms with left complete obstructive thrombus in intravenous immunoglobulin-sensitive Kawasaki disease: a case report.静脉注射免疫球蛋白敏感型川崎病致巨大双侧腋动脉动脉瘤伴左侧完全性血栓形成:病例报告。
Pediatr Rheumatol Online J. 2021 Nov 8;19(1):157. doi: 10.1186/s12969-021-00643-w.
5
Kawasaki disease - A common childhood vasculitis.川崎病——一种常见的儿童血管炎。
Indian J Rheumatol. 2015 Dec;10:S78-S83. doi: 10.1016/j.injr.2015.07.010. Epub 2015 Oct 1.
6
Kawasaki disease in infants three months of age or younger.三个月及以下婴儿的川崎病。
J Microbiol Immunol Infect. 2006 Oct;39(5):387-91.
7
A retrospective cohort study of major adverse cardiac events in children affected by Kawasaki disease with coronary artery aneurysms in Thailand.泰国川崎病伴冠状动脉瘤患儿主要不良心脏事件的回顾性队列研究。
PLoS One. 2022 Jan 27;17(1):e0263060. doi: 10.1371/journal.pone.0263060. eCollection 2022.
8
Comparison of Demographic, Clinical, and Echocardiographic Features Between Complete and Incomplete, and Early and Late Presenters of Kawasaki Disease: A 10-Year Single-Center Experience.川崎病完全型与不完全型、早发型与晚发型患者的人口统计学、临床及超声心动图特征比较:一项为期10年的单中心经验
Cureus. 2023 Sep 23;15(9):e45819. doi: 10.7759/cureus.45819. eCollection 2023 Sep.
9
Kawasaki disease in infants less than one year of age: an Italian cohort from a single center.一岁以下婴儿川崎病:单中心意大利队列研究。
BMC Pediatr. 2019 Sep 7;19(1):321. doi: 10.1186/s12887-019-1695-0.
10
Analysis of Age, Sex, Lack of Response to Intravenous Immunoglobulin, and Development of Coronary Artery Abnormalities in Children With Kawasaki Disease in Japan.日本川崎病患儿的年龄、性别、静脉注射免疫球蛋白无反应和冠状动脉异常分析。
JAMA Netw Open. 2022 Jun 1;5(6):e2216642. doi: 10.1001/jamanetworkopen.2022.16642.

引用本文的文献

1
Cutaneous signs of selected cardiovascular disorders: A narrative review.特定心血管疾病的皮肤表现:一篇叙述性综述。
Open Med (Wars). 2024 Feb 2;19(1):20240897. doi: 10.1515/med-2024-0897. eCollection 2024.
2
[Clinical details in the diagnosis of Kawasaki disease].[川崎病诊断中的临床细节]
Zhongguo Dang Dai Er Ke Za Zhi. 2022 Dec 15;24(12):1307-1310. doi: 10.7499/j.issn.1008-8830.2208124.
3
A Sri Lankan infant with immunoglobulin resistant incomplete Kawasaki disease with a vesicular psoriasiform rash, hypertension and late onset small joint arthritis: a case report.

本文引用的文献

1
Infliximab is the new kid on the block in Kawasaki disease: a single-centre study over 8 years from North India.英夫利昔单抗在川崎病治疗中是个新事物:一项来自印度北部的为期8年的单中心研究。
Clin Exp Rheumatol. 2016 May-Jun;34(3 Suppl 97):S134-8. Epub 2016 Apr 15.
2
Kawasaki disease in infants below 6 months: a clinical conundrum?6个月以下婴儿的川崎病:一个临床难题?
Int J Rheum Dis. 2016 Sep;19(9):924-8. doi: 10.1111/1756-185X.12854. Epub 2016 Mar 16.
3
Psoriasiform eruptions during Kawasaki disease (KD): A distinct phenotype.川崎病(KD)期间的银屑病样皮疹:一种独特的表型。
一名斯里兰卡婴儿患有免疫球蛋白耐药性不完全川崎病,伴有水疱样银屑病样皮疹、高血压和迟发性小关节关节炎:一例报告。
BMC Pediatr. 2022 Jul 23;22(1):444. doi: 10.1186/s12887-022-03510-z.
4
Clinical Manifestations and Laboratory Findings of Kawasaki Disease: Beyond the Classic Diagnostic Features.川崎病的临床表现和实验室检查:超越经典诊断特征。
Medicina (Kaunas). 2022 May 30;58(6):734. doi: 10.3390/medicina58060734.
5
Cutaneous manifestations of acute kidney injury.急性肾损伤的皮肤表现。
Clin Kidney J. 2021 Dec 9;15(5):855-864. doi: 10.1093/ckj/sfab255. eCollection 2022 May.
6
Staphylococcal Scalded Skin Syndrome and Bullous Impetigo.葡萄球菌性烫伤样皮肤综合征和大疱性脓疱疮。
Medicina (Kaunas). 2021 Oct 24;57(11):1157. doi: 10.3390/medicina57111157.
7
COVID-19 cutaneous manifestations in pediatric patients: 24 multisystem inflammatory syndrome in children and six Kawasaki disease cases.儿童 COVID-19 的皮肤表现:24 例儿童多系统炎症综合征和 6 例川崎病病例。
J Eur Acad Dermatol Venereol. 2022 Mar;36(3):e180-e182. doi: 10.1111/jdv.17828. Epub 2021 Dec 1.
8
Multisystem Inflammatory Syndrome in Children Associated with COVID-19: A Review with an Emphasis on Mucocutaneous and Kawasaki Disease-Like Findings.儿童多系统炎症综合征与 COVID-19 相关:一项以黏膜皮肤和川崎病样表现为重点的综述。
Dermatology. 2022;238(1):35-43. doi: 10.1159/000515449. Epub 2021 Jun 1.
9
Multisystem Inflammatory Syndrome in a Child with Scrub Typhus and Macrophage Activation Syndrome.儿童恙虫病伴巨噬细胞活化综合征所致多系统炎症综合征。
J Trop Pediatr. 2021 Jan 29;67(1). doi: 10.1093/tropej/fmab021.
10
Incomplete Kawasaki disease complicated with acute abdomen: A case report.不完全川崎病合并急腹症:一例报告。
World J Clin Cases. 2020 Nov 6;8(21):5457-5466. doi: 10.12998/wjcc.v8.i21.5457.
J Am Acad Dermatol. 2016 Jul;75(1):69-76.e2. doi: 10.1016/j.jaad.2016.02.1146. Epub 2016 Mar 4.
4
Kawasaki Disease in India, Lessons Learnt Over the Last 20 Years.印度的川崎病:过去20年的经验教训
Indian Pediatr. 2016 Feb;53(2):119-24. doi: 10.1007/s13312-016-0804-5.
5
Mortality in children with Kawasaki disease: 20 years of experience from a tertiary care centre in North India.川崎病患儿的死亡率:来自印度北部一家三级医疗中心的20年经验
Clin Exp Rheumatol. 2016 May-Jun;34(3 Suppl 97):S129-33. Epub 2015 Nov 17.
6
Kawasaki disease in adults: Observations in France and literature review.成人川崎病:法国的观察结果和文献回顾。
Autoimmun Rev. 2016 Mar;15(3):242-9. doi: 10.1016/j.autrev.2015.11.010. Epub 2015 Nov 26.
7
Measurements of Coronary Artery Aneurysms Due to Kawasaki Disease by Dual-Source Computed Tomography (DSCT).双源计算机断层扫描(DSCT)对川崎病所致冠状动脉瘤的测量
Pediatr Cardiol. 2016 Mar;37(3):442-7. doi: 10.1007/s00246-015-1297-z. Epub 2015 Oct 29.
8
Kawasaki Disease: Issues in Diagnosis and Treatment--A Developing Country Perspective.川崎病:诊断与治疗中的问题——发展中国家视角
Indian J Pediatr. 2016 Feb;83(2):140-5. doi: 10.1007/s12098-015-1890-4. Epub 2015 Sep 24.
9
Recent Advances in Kawasaki Disease - Proceedings of the 3rd Kawasaki Disease Summit, Chandigarh, 2014.川崎病的最新进展——2014年于昌迪加尔举行的第三届川崎病峰会会议论文集
Indian J Pediatr. 2016 Jan;83(1):47-52. doi: 10.1007/s12098-015-1858-4. Epub 2015 Aug 30.
10
The epidemiology of Kawasaki disease: a global update.川崎病的流行病学:全球最新情况
Arch Dis Child. 2015 Nov;100(11):1084-8. doi: 10.1136/archdischild-2014-307536. Epub 2015 Jun 25.